Gottlieb Looks Like Good Fit At FDA Helm To Supplement Industry

Scott Gottlieb’s two stints at FDA and his support for limiting regulation that impedes innovation bode well for a supplement industry anxious for guidance on NDI notifications that aligns more with its expectation for less burdensome requirements than those the agency has stated.